Ressources

Polysubstance use (PSU) is common among people who use opioids (PWUO) and has been associated with drug-related harms.

This study examines the relationship between social determinants of health (SDOH), mental health, substance-use and recidivism among women exiting prison with histories of substance-use.

To determine if a positive urine drug test (UDT) for stimulants was associated with subsequent opioid-related harm or discontinuation of long-term opioid therapy (LTOT).

We analyzed the trend in substance use disorder (SUD) treatment integration among traditional mental health (MH) facilities in the US from 2014 to 2020 and identified facility-level factors associa

Little research has examined the association between urine drug screening (UDS) modality and retention in opioid treatment providers (OTPs).

Children in families affected by substance use disorders are at high risk of being placed in out-of-home care (OOHC).

Studies point to the many advantages inherent in such peer work, especially for the aid providers.

Examining the effectiveness of involuntary treatment for individuals with substance use disorders (SUDs).

To describe the sociodemographic characteristics of a cohort of people who use methamphetamine with a history of hospitalizations in London, Ontario, including their substance use patterns, health

To compare time on treatment among individuals initiating buprenorphine/naloxone and methadone and understand how retention varies according to age, sex, and urban/rural residence.

The purpose of this systematic scoping review is to: 1) review published curricula on harm reduction for substance use implemented by undergraduate (UME) and graduate medical education (GME) in the

To identify the association of benzodiazepine discontinuation with mortality and other adverse events among patients prescribed stable long-term benzodiazepine therapy, stratified by baseline

Fatal overdoses involving fentanyl/fentanyl analogs (F/FA) have increased in the US, raising questions about naloxone doses for F/FA overdose reversal.

Responding to increasing rates of illicit drug toxicity mortality in British Columbia, regional health authorities introduced various types and models of drug checking services starting in 2016.